StockData
PetMed Express Inc logo

PetMed Express Inc (PETS) stock

PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3069% below fair value
$0.90+0.00 (+0.20%)

Close on Nov 18, 2026Market cap $19.54MP/E –Yield 0.00%

PetMed Express free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

PetMed Express's free cash flow for the twelve months ending Jun 30, 2026 was -$27.77M. For fiscal 2026 it was -$33.01M. The highest annual figure on record is $44.52M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$33.01M–
FY2025Mar 31, 2025-$395.00K–
FY2024Mar 31, 2024-$194.00K-100.9%
FY2023Mar 31, 2023$22.54M+34.6%
FY2022Mar 31, 2022$16.75M-55.5%
FY2021Mar 31, 2021$37.64M+3.0%
FY2020Mar 31, 2020$36.53M-17.9%
FY2019Mar 31, 2019$44.52M+21.4%
FY2018Mar 31, 2018$36.68M+0.2%
FY2017Mar 31, 2017$36.60M+3865.3%
FY2016Mar 31, 2016$923.00K-97.0%
FY2015Mar 31, 2015$31.13M+131.2%
FY2014Mar 31, 2014$13.46M+6.3%
FY2013Mar 31, 2013$12.66M-35.7%
FY2012Mar 31, 2012$19.69M-33.1%
FY2011Mar 31, 2011$29.44M+10.5%
FY2010Mar 31, 2010$26.64M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$8.33M–
Q4 FY2026CQ1 2026Mar 31, 2026-$5.46M-218.2%
Q3 FY2026CQ4 2025Dec 31, 2025-$9.18M–
Q2 FY2026CQ3 2025Sep 30, 2025-$4.80M-178.3%
Q1 FY2026CQ2 2025Jun 30, 2025-$13.56M–
Q4 FY2025CQ1 2025Mar 31, 2025$4.62M-21.3%
Q3 FY2025CQ4 2024Dec 31, 2024-$1.94M–
Q2 FY2025CQ3 2024Sep 30, 2024$6.12M–
Q1 FY2025CQ2 2024Jun 30, 2024-$9.20M–
Q4 FY2024CQ1 2024Mar 31, 2024$5.87M-24.6%
Q3 FY2024CQ4 2023Dec 31, 2023-$3.72M-131.0%
Q2 FY2024CQ3 2023Sep 30, 2023-$1.76M–
Q1 FY2024CQ2 2023Jun 30, 2023-$591.00K-110.9%
Q4 FY2023CQ1 2023Mar 31, 2023$7.79M-5.3%
Q3 FY2023CQ4 2022Dec 31, 2022$11.98M+42.4%
Q2 FY2023CQ3 2022Sep 30, 2022-$2.63M-362.1%
Q1 FY2023CQ2 2022Jun 30, 2022$5.40M–
Q4 FY2022CQ1 2022Mar 31, 2022$8.23M-53.9%
Q3 FY2022CQ4 2021Dec 31, 2021$8.41M+45.5%
Q2 FY2022CQ3 2021Sep 30, 2021$1.00M-96.0%
Q1 FY2022CQ2 2021Jun 30, 2021-$899.00K–
Q4 FY2021CQ1 2021Mar 31, 2021$17.87M+6.5%
Q3 FY2021CQ4 2020Dec 31, 2020$5.78M+101.3%
Q2 FY2021CQ3 2020Sep 30, 2020$25.34M+48.8%
Q1 FY2021CQ2 2020Jun 30, 2020-$11.35M–
Q4 FY2020CQ1 2020Mar 31, 2020$16.78M+29.1%
Q3 FY2020CQ4 2019Dec 31, 2019$2.87M-75.2%
Q2 FY2020CQ3 2019Sep 30, 2019$17.03M–
Q1 FY2020CQ2 2019Jun 30, 2019-$156.00K-100.7%
Q4 FY2019CQ1 2019Mar 31, 2019$13.00M+520.5%
Q3 FY2019CQ4 2018Dec 31, 2018$11.57M-30.4%
Q2 FY2019CQ3 2018Sep 30, 2018-$1.78M-143.3%
Q1 FY2019CQ2 2018Jun 30, 2018$21.73M+56.8%
Q4 FY2018CQ1 2018Mar 31, 2018$2.10M-85.9%
Q3 FY2018CQ4 2017Dec 31, 2017$16.63M–
Q2 FY2018CQ3 2017Sep 30, 2017$4.10M-64.1%
Q1 FY2018CQ2 2017Jun 30, 2017$13.85M–
Q4 FY2017CQ1 2017Mar 31, 2017$14.82M–
Q3 FY2017CQ4 2016Dec 31, 2016-$144.00K–
Q2 FY2017CQ3 2016Sep 30, 2016$11.42M–

More PetMed Express figures

See a number that looks wrong?